NEENAH, Wis.--(BUSINESS WIRE)--The Board of Directors of Bemis Company, Inc. (NYSE:BMS) announced today that Adele M. Gulfo was elected to the Board of Directors, effective June 23, 2015.
Ms. Gulfo is Chief Strategy Officer of Mylan N.V. (Nasdaq: MYL), a leading global pharmaceutical company, since 2014. Prior to joining Mylan, Ms. Gulfo spent four years at Pfizer, Inc., most recently as President, Latin America, and before that as President and General Manager, U.S. Primary Care. Previously, Ms. Gulfo held leadership positions at AstraZeneca Pharmaceuticals, Parke-Davis (Division of Warner-Lambert), SpectraTech Inc., and Fischer Scientific.
“We are pleased that Adele is joining our Board of Directors,” said William F. Austen, Bemis Company’s President and Chief Executive Officer. “She brings valuable pharmaceutical, marketing, and strategic insight to our board. We look forward to her contributions and energy.”
ABOUT BEMIS COMPANY, INC.
Bemis Company, Inc. (“Bemis” or the “Company”) is a major supplier of flexible packaging used by leading food, consumer products, healthcare, and other companies worldwide. Founded in 1858, Bemis reported 2014 net sales from continuing operations of $4.3 billion. Bemis has a strong technical base in polymer chemistry, film extrusion, coating and laminating, printing, and converting. Headquartered in Neenah, Wisconsin, Bemis employs approximately 17,000 individuals worldwide. More information about Bemis is available at our website, www.bemis.com.